Companies Dominating the Transthyretin Stabilizers Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Ionis Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals, Inc.
- Akcea Therapeutics, Inc.
- Eidos Therapeutics, Inc.
- FoldRx Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Prothena Corporation plc
- Ionis/Biogen
- Coherus BioSciences, Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Ionis merged its wholly-owned subsidiary Alnylam Pharmaceuticals Ireland Ltd. with Ionis Pharmaceuticals Ireland Ltd. This strategic merger streamlined operations and improved efficiency within the European market.
- Ionis merged its wholly-owned subsidiary Ionis Pharmaceuticals USA, Inc. with Ionis Pharmaceuticals, Inc. in 2022. This merger simplified the company's corporate structure and consolidated operations within the US market.
